Discovery of Molecular Mechanisms of Traditional Chinese Medicinal Formula Si-Wu-Tang Using Gene Expression Microarray and Connectivity Map

Abstract

To pursue a systematic approach to discovery of mechanisms of action of traditional Chinese medicine (TCM), we used microarrays, bioinformatics and the “Connectivity Map” (CMAP) to examine TCM-induced changes in gene expression. We demonstrated that this approach can be used to elucidate new molecular targets using a model TCM herbal formula Si-Wu-Tang (SWT) which is widely used for women's health. The human breast cancer MCF-7 cells treated with 0.1 µM estradiol or 2.56 mg/ml of SWT showed dramatic gene expression changes, while no significant change was detected for ferulic acid, a known bioactive compound of SWT. Pathway analysis using differentially expressed genes related to the treatment effect identified that expression of genes in the nuclear factor erythroid 2-related factor 2 (Nrf2) cytoprotective pathway was most significantly affected by SWT, but not by estradiol or ferulic acid. The Nrf2-regulated genes HMOX1, GCLC, GCLM, SLC7A11 and NQO1 were upreguated by SWT in a dose-dependent manner, which was validated by real-time RT-PCR. Consistently, treatment with SWT and its four herbal ingredients resulted in an increased antioxidant response element (ARE)-luciferase reporter activity in MCF-7 and HEK293 cells. Furthermore, the gene expression profile of differentially expressed genes related to SWT treatment was used to compare with those of 1,309 compounds in the CMAP database. The CMAP profiles of estradiol-treated MCF-7 cells showed an excellent match with SWT treatment, consistent with SWT's widely claimed use for women's diseases and indicating a phytoestrogenic effect. The CMAP profiles of chemopreventive agents withaferin A and resveratrol also showed high similarity to the profiles of SWT. This study identified SWT as an Nrf2 activator and phytoestrogen, suggesting its use as a nontoxic chemopreventive agent, and demonstrated the feasibility of combining microarray gene expression profiling with CMAP mining to discover mechanisms of actions and to identify new health benefits of TCMs.

A review of connectivity map and computational approaches in pharmacogenomics

“…Interestingly, the extracts of the Paris polyphylla plant, containing polyphyllin D, have been long used in traditional Chinese medicine for cancer treatment [72]. Their CMap analysis indicated that polyphyllin D is a trigger for estrogen receptorinduced apoptosis and mitochondria-mediated apoptotic pathways [73].…”

Protective effect of curcumin against cardiac dysfunction in sepsis rats

“…Traditional Chinese medicines (TCMs) have been used in China and other Asian countries for thousands years for the prevention and treatment of a wide variety of diseases (Peng et al, 2011;Wen et al, 2011). Curcumin comes from the rhizome of Curcuma longa, and has broader pharmacological activities.…”

Bioactivities and serum pharmacochemistry ofQi-Wei-Xiao-Yan-Tang

“…Therefore, it is also demonstrated that XYT has a promising therapeutic value as an antiinflammatory drug. Traditional Chinese medicines (TCMs) have been used in China and other Asian countries for thousands years for the prevention and treatment of a wide variety of diseases (Wen et al, 2011). There are a large number of herbal formulations in TCMs, most of them contain a mixture of herbs, and multiple constituents are responsible for their bioactivities.…”